BL
JAZZ icon

BFSG LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

BFSG LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Buy
+5,939
New +$1.04M 0.11% 159
2024
Q1 		– Sell
-3
Closed -$369 – 683
2023
Q4 		$369 Buy
+3
New +$374 ﹤0.01% 589
2020
Q2 		– Sell
-19,845
Closed -$1.98M – 171
2020
Q1 		$1.98M Buy
+19,845
New +$2.57M 0.51% 66

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BFSG LLC's JAZZ Position: Q1 2026 in Review

BFSG LLC opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 5,939 shares worth $1.12M. The stake represents 0.11% of the portfolio and ranks #159 among its holdings. This is a return to the name: BFSG LLC previously reported a position in JAZZ as recently as Q4 2023.

BFSG LLC first reported a position in JAZZ in Q1 2020 and has held it in 3 quarters since. The position peaked at $1.98M in Q1 2020. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • BFSG LLC held 5,939 shares of Jazz Pharmaceuticals worth $1.12M as of Q1 2026.
  • Jazz Pharmaceuticals was a new BFSG LLC position in Q1 2026.
  • Jazz Pharmaceuticals made up 0.11% of BFSG LLC's portfolio in Q1 2026, its #159 holding.
  • BFSG LLC first reported a position in Jazz Pharmaceuticals in Q1 2020 and has held it in 3 quarters since.
  • BFSG LLC's Jazz Pharmaceuticals position peaked at $1.98M in Q1 2020.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on BFSG LLC's 13F filing for Q1 2026, filed 29 Apr 2026.